Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil boosts elastin production, potentially helping skin diseases.

The new method is rapid, sensitive, and accurate for evaluating the quality of the medicinal herb Platycladi cacumen.

A new compound shows promise as a topical treatment for hair loss.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The hair follicle's connective tissue is a key source of a certain collagen in human scalp skin.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.

Drugs like PDEI may help hair disorders like AGA.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Monilethrix causes short, fragile hair with no specific treatment available.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

The Multi-Organ-Chip improves the growth and quality of skin and hair in the lab, potentially replacing animal testing.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

Current treatments for alopecia show no significant long-term benefits.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

KGF and activin are crucial for skin healing and repair.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Skin fat helps with body temperature control and has other active roles in health.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Smart biomaterials that guide tissue repair are key for future medical treatments.